BMY - Schrodinger gets rights to cancer drug candidate back from Bristol
2024-05-02 15:04:30 ET
More on Bristol Myers, Schrödinger
- Schrödinger, Inc. (SDGR) Q1 2024 Earnings Call Transcript
- Schrödinger, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Bristol Myers Squibb: Tough Times Continue
- Schrodinger tumbles 8% on Q1 misses; drug discovery revenue plummets
- Schrödinger misses top-line and bottom-line estimates; initiates Q2 and reaffirms FY24 outlook